CIK: 0001602263
Total reported value
$379.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TXG | 10x Genomics Inc-class A | Stock-Other | 34.31% | +1.60% | — | |
| 2 | BHVN | Biohaven Ltd. | Stock-Other | 11.33% | -4.69% | -25.96% | |
| 3 | ASND | Ascendis Pharma A/S | Stock-Other | 8.61% | -8.61% | EXIT | |
| 4 | SWAVUSD | Shockwave Medical INC | Stock-Other | 7.37% | -4.03% | -28.27% | |
| 5 | ✓ | Obseva SA | Stock-Other | 7.15% | -5.57% | — | |
| 6 | AXSM | Axsome Therapeutics INC | Stock-Healthcare | 6.89% | +14.53% | — | |
| 7 | RARXEUR | Ra Pharmaceuticals INC | Stock-Other | 6.10% | -6.10% | EXIT | |
| 8 | BCRX | Biocryst Pharmaceuticals INC | Stock-Other | 3.14% | -3.14% | EXIT | |
| 9 | PTGX | Protagonist Therapeutics INC | Stock-Other | 1.95% | -1.89% | — | |
| 10 | SPRO | Spero Therapeutics INC | Stock-Other | 1.91% | -0.72% | — | |
| 11 | CNST | Constellation Pharmaceutical | Stock-Other | 1.79% | +16.85% | — | |
| 12 | KNSA | Kiniksa Pharmaceuticals International, plc | Stock-Other | 1.75% | -1.75% | EXIT | |
| 13 | LJPC | La Jolla Pharmaceutical Co | Stock-Other | 1.74% | -1.74% | EXIT | |
| 14 | 4XC1 | Kalvista Pharmaceuticals INC | Stock-Other | 1.67% | +0.05% | — | |
| 15 | 1T7 | Tricida INC | Stock-Other | 1.40% | -1.40% | EXIT | |
| 16 | MIST | Milestone Pharmaceuticals In | Stock-Other | 1.06% | -0.43% | — | |
| 17 | MRNSUSD | Marinus Pharmaceuticals INC | Stock-Other | 0.87% | -0.02% | +99.86% | |
| 18 | BLPHEUR | Bellerophon Therapeutics INC | Stock-Other | 0.76% | -0.70% | — | |
| 19 | RDUSEUR | Radius Health INC | Stock-Other | 0.13% | -0.13% | EXIT | |
| 20 | PTIEUR | Proteostasis Therapeutics In | Stock-Other | 0.04% | -0.04% | EXIT | |
| 21 | ✓ | Prevail Therapeutics INC | Stock-Other | 0.01% | -0.01% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | PTGX | Protagonist Therapeutics INC | +0.3% | — | Unchanged |
| 2 | LJPC | La Jolla Pharmaceutical Co | +0.2% | — | Unchanged |
| 3 | SPRO | Spero Therapeutics INC | +0.2% | — | Unchanged |
| 4 | PTIEUR | Proteostasis Therapeutics In | — | — | Unchanged |
| 5 | BLPHEUR | Bellerophon Therapeutics INC | 0% | — | Unchanged |
| 6 | MRNSUSD | Marinus Pharmaceuticals INC | -0.1% | +99.86% | Add |
| 7 | MIST | Milestone Pharmaceuticals In | -0.2% | — | Unchanged |
| 8 | BCRX | Biocryst Pharmaceuticals INC | -0.3% | — | Unchanged |
| 9 | RARXEUR | Ra Pharmaceuticals INC | -0.3% | — | Unchanged |
| 10 | AXSM | Axsome Therapeutics INC | -0.4% | — | Unchanged |
| 11 | KNSA | Kiniksa Pharmaceuticals International, plc | -0.9% | -11.27% | Trim |
| 12 | ✓ | Obseva SA | -0.9% | — | Unchanged |
| 13 | 4XC1 | Kalvista Pharmaceuticals INC | -1% | — | Unchanged |
| 14 | CNST | Constellation Pharmaceutical | -1% | — | Unchanged |
| 15 | BHVN | Biohaven Ltd. | -2% | -25.96% | Trim |
| 16 | 1T7 | Tricida INC | -3.9% | -72.27% | Trim |
| 17 | SWAVUSD | Shockwave Medical INC | -8.9% | -28.27% | Trim |
| 18 | ASND | Ascendis Pharma A/S | -9.7% | -53.47% | Trim |
| 19 | TXG | 10x Genomics Inc-class A | — | NEW | New buy |
| 20 | ZGNXEUR | Zogenix INC | — | EXIT | Sold out |
| 21 | KDMN | Kadmon Holdings INC | — | EXIT | Sold out |
| 22 | ✓ | Gemphire Therapeutics INC | — | EXIT | Sold out |
| 23 | RDUSEUR | Radius Health INC | — | NEW | New buy |
| 24 | ✓ | Prevail Therapeutics INC | — | NEW | New buy |